Pearl Steinzor

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments being made with novel biomarkers.

Amazon Pharmacy's RxPass program shows promise in boosting medication adherence and reducing costs, according to a study.

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.

FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Waist circumference and waist-to-hip ratio show stronger links to colorectal cancer (CRC) than body mass index (BMI), a new study has found.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.

Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in higher costs and worse population-level outcomes.

The FDA cites cancer risk and the Delaney Clause in its decision to revoke food and drug uses of the dye.

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality of life for patients with psoriasis.

There is limited awareness and utilization of supplemental benefits among Medicare Advantage beneficiaries, with cost-sharing and out-of-pocket spending playing key roles, a new study has found.

New research examines how ethnicity impacts colorectal cancer diagnosis, early-onset colorectal cancer (CRC) prevalence, and stage at diagnosis.

Secukinumab delivers sustained efficacy and quality of life improvements in pediatric generalized pustular psoriasis (GPP).

Psychological resilience plays an important role in managing psoriasis symptoms and enhancing patient well-being, study reveals.

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in patients with hormone receptor–positive breast cancer.

Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in patients with resected colorectal cancer (CRC).

Trend tracking and harm reduction policies may help alleviate the high rate of overdose deaths in the US, according to one study.

Record numbers have enrolled in Affordable Care Act (ACA) coverage as open enrollment continues through January 15, 2025.

Study highlights barriers to care, treatment preferences, and interest in research participation in psoriasis in the Latine community.

Self-efficacy–based sexual counseling may improve sexual function among breast cancer survivors, study finds.

Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, continues his discussion on treatment approaches for patients with cardiovascular-kidney-metabolic (CKM) syndrome.

How does age, sex, comorbidity, and screening history influence the cost-effectiveness of continuing colorectal cancer (CRC) screening in older adults?